These assessments measure an elderly person's neurocognitive status in relation to dementia.
Tests such as the Clinical Assessment Scales for the Elderly (CASE) assist in the clinical diagnosis of the most prominent DSM-1V™ disorders among the elderly, such as anxiety, cognitive competence, depression, fear of ageing, mania, obsessive-compulsive behaviour, paranoia, psychoticism, somatisation and substance abuse.
The MTOA assessment is specifically designed to assess verbal and visuospatial learning and memory in older adults ages 55 to 84 years. It can be used in mental health and primary care settings to assess a patient's degree and type of memory impairment (e.g. genuine memory loss vs. retrieval failure) for the purposes of diagnosis, placement, intervention planning, or as an indicator of change during treatment. The MTOA assessment uses tasks that are well-established in the assessment of verbal and visuospatial learning and memory.